These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3135102)

  • 1. Effects of a one-year administration of phosphate and intermittent calcitonin on bone-forming and bone-resorbing cells in involutional osteoporosis: a histomorphometric study.
    Alexandre C; Chappard D; Caulin F; Bertrand A; Palle S; Riffat G
    Calcif Tissue Int; 1988 Jun; 42(6):345-50. PubMed ID: 3135102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ; Caulin F
    Bone; 1986; 7(1):17-22. PubMed ID: 3964494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of calcitonin and vitamin D in osteoporosis.
    Palmieri GM; Pitcock JA; Brown P; Karas JG; Roen LJ
    Calcif Tissue Int; 1989 Sep; 45(3):137-41. PubMed ID: 2505903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.
    Hodsman AB; Kisiel M; Adachi JD; Fraher LJ; Watson PH
    Bone; 2000 Aug; 27(2):311-8. PubMed ID: 10913928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH; Majumdar S; Newitt DC; Shields A; Van Pelt J; Laschansky E; Azria M; Kriegman A; Olson M; Eriksen EF; Mindeholm L
    J Bone Miner Res; 2005 Sep; 20(9):1548-61. PubMed ID: 16059627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin and calcium combined therapy in osteoporosis: effects on vertebra trabecular bone density.
    Ozoran K; Paker N; Başgöze O; Hasçelik Z; Erzen C; Narman S; Ozker R
    J Int Med Res; 1989; 17(4):395-400. PubMed ID: 2792558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients.
    Hodsman AB; Steer BM; Fraher LJ; Drost DJ
    Bone Miner; 1991 Jul; 14(1):67-83. PubMed ID: 1868270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
    Civitelli R; Gonnelli S; Zacchei F; Bigazzi S; Vattimo A; Avioli LV; Gennari C
    J Clin Invest; 1988 Oct; 82(4):1268-74. PubMed ID: 3262626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcitonin administration on young pig trabecular bone remodeling.
    de Vernejoul MC; Pointillart A; Bourdeau A; Morieux C; Modrowski D; Miravet L; Caulin F
    Bone; 1990; 11(1):29-33. PubMed ID: 2331428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
    Reeve J; Meunier PJ; Parsons JA; Bernat M; Bijvoet OL; Courpron P; Edouard C; Klenerman L; Neer RM; Renier JC; Slovik D; Vismans FJ; Potts JT
    Br Med J; 1980 Jun; 280(6228):1340-4. PubMed ID: 6992932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New concepts in the treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ
    Postgrad Med; 1972 Oct; 52(4):62-7. PubMed ID: 5070959
    [No Abstract]   [Full Text] [Related]  

  • 14. Involutional osteoporosis.
    Riggs BL; Melton LJ
    N Engl J Med; 1986 Jun; 314(26):1676-86. PubMed ID: 3520321
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium and salmon calcitonin in treatment of osteoporosis.
    Jowsey J; Riggs BL; Kelly PJ; Hoffman DL
    J Clin Endocrinol Metab; 1978 Sep; 47(3):633-9. PubMed ID: 263316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histomorphometry. Method for evaluating the bone mass].
    Meunier PJ; Chavassieux P
    Rev Rhum Mal Osteoartic; 1985 Dec; 52(12):669-73. PubMed ID: 4095470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine.
    Szücs J; Horváth C; Kollin E; Szathmári M; Holló I
    Calcif Tissue Int; 1992 Jan; 50(1):7-10. PubMed ID: 1739873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prolonged administration of porcine calcitonin in postmenopausal osteoporosis.
    Jowsey J; Riggs BL; Goldsmith RS; Kelly PJ; Arnaud CD
    J Clin Endocrinol Metab; 1971 Nov; 33(5):752-8. PubMed ID: 4942159
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of osteoporotic syndromes and the response to calcitonin therapy.
    Avioli LV
    Calcif Tissue Int; 1991; 49 Suppl 2():S16-9. PubMed ID: 1933615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.